secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001193125-26-048696
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics enters retention bonus agreement with CAO Joel Sussman for up to $250,000
--------------------------------------------------------------------------------

- Up to $250,000 in retention bonuses tied to timely completion and filing of reporting obligations.
- Retention payments reduce severance payments under existing employment agreement dollar-for-dollar.
- Unpaid bonus accelerates if involuntary termination (not for cause) or good reason occurs.
- Agreement dated February 6, 2026, with payments tied to specific conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526048696/0001193125-26-048696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526048696/d892515d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-048696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer